A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
Clinical trial NCT05005273 · COMPLETED
Trial details
- NCT number
- NCT05005273
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-03
- Primary completion
- 2022-12-27
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.